The Market Reports

Index

1 Osteoarthritis Drugs Market Overview
1.1 Product Overview and Scope of Osteoarthritis Drugs
1.2 Osteoarthritis Drugs Segment by Type
1.2.1 Global Osteoarthritis Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Osteoarthritis Drugs Segment by Application
1.3.1 Global Osteoarthritis Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Osteoarthritis Drugs Market Size Estimates and Forecasts
1.4.1 Global Osteoarthritis Drugs Revenue 2016-2027
1.4.2 Global Osteoarthritis Drugs Sales 2016-2027
1.4.3 Osteoarthritis Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Osteoarthritis Drugs Market Competition by Manufacturers
2.1 Global Osteoarthritis Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Osteoarthritis Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Osteoarthritis Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Osteoarthritis Drugs Manufacturing Sites, Area Served, Product Type
2.5 Osteoarthritis Drugs Market Competitive Situation and Trends
2.5.1 Osteoarthritis Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Osteoarthritis Drugs Players Market Share by Revenue
2.5.3 Global Osteoarthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Osteoarthritis Drugs Retrospective Market Scenario by Region
3.1 Global Osteoarthritis Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Osteoarthritis Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Osteoarthritis Drugs Market Facts & Figures by Country
3.3.1 North America Osteoarthritis Drugs Sales by Country
3.3.2 North America Osteoarthritis Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Osteoarthritis Drugs Market Facts & Figures by Country
3.4.1 Europe Osteoarthritis Drugs Sales by Country
3.4.2 Europe Osteoarthritis Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Osteoarthritis Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Osteoarthritis Drugs Sales by Region
3.5.2 Asia Pacific Osteoarthritis Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Osteoarthritis Drugs Market Facts & Figures by Country
3.6.1 Latin America Osteoarthritis Drugs Sales by Country
3.6.2 Latin America Osteoarthritis Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Osteoarthritis Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Osteoarthritis Drugs Sales by Country
3.7.2 Middle East and Africa Osteoarthritis Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Osteoarthritis Drugs Historic Market Analysis by Type
4.1 Global Osteoarthritis Drugs Sales Market Share by Type (2016-2021)
4.2 Global Osteoarthritis Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Osteoarthritis Drugs Price by Type (2016-2021)

5 Global Osteoarthritis Drugs Historic Market Analysis by Application
5.1 Global Osteoarthritis Drugs Sales Market Share by Application (2016-2021)
5.2 Global Osteoarthritis Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Osteoarthritis Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Johnson & Johnson Osteoarthritis Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer Osteoarthritis Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Eli Lilly Osteoarthritis Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Abbott Osteoarthritis Drugs Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 GlaxoSmithKline Osteoarthritis Drugs Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Sanofi Osteoarthritis Drugs Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 Flexion Therapeutics
6.6.1 Flexion Therapeutics Corporation Information
6.6.2 Flexion Therapeutics Description and Business Overview
6.6.3 Flexion Therapeutics Osteoarthritis Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Flexion Therapeutics Osteoarthritis Drugs Product Portfolio
6.7.5 Flexion Therapeutics Recent Developments/Updates

7 Osteoarthritis Drugs Manufacturing Cost Analysis
7.1 Osteoarthritis Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Osteoarthritis Drugs
7.4 Osteoarthritis Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Osteoarthritis Drugs Distributors List
8.3 Osteoarthritis Drugs Customers

9 Osteoarthritis Drugs Market Dynamics
9.1 Osteoarthritis Drugs Industry Trends
9.2 Osteoarthritis Drugs Growth Drivers
9.3 Osteoarthritis Drugs Market Challenges
9.4 Osteoarthritis Drugs Market Restraints

10 Global Market Forecast
10.1 Osteoarthritis Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Osteoarthritis Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Osteoarthritis Drugs by Type (2022-2027)
10.2 Osteoarthritis Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Osteoarthritis Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Osteoarthritis Drugs by Application (2022-2027)
10.3 Osteoarthritis Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Osteoarthritis Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Osteoarthritis Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Osteoarthritis Drugs Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Osteoarthritis Drugs Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Osteoarthritis Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Osteoarthritis Drugs Covered in This Study
Table 5. Global Osteoarthritis Drugs Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Osteoarthritis Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Osteoarthritis Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Osteoarthritis Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Osteoarthritis Drugs Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Osteoarthritis Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Osteoarthritis Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Osteoarthritis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Osteoarthritis Drugs Sales by Region (2016-2021) & (MT)
Table 16. Global Osteoarthritis Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Osteoarthritis Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Osteoarthritis Drugs Sales by Country (2016-2021) & (MT)
Table 19. North America Osteoarthritis Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Osteoarthritis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Osteoarthritis Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Osteoarthritis Drugs Sales by Country (2016-2021) & (MT)
Table 23. Europe Osteoarthritis Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Osteoarthritis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Osteoarthritis Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Osteoarthritis Drugs Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Osteoarthritis Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Osteoarthritis Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Osteoarthritis Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Osteoarthritis Drugs Sales by Country (2016-2021) & (MT)
Table 31. Latin America Osteoarthritis Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Osteoarthritis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Osteoarthritis Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Osteoarthritis Drugs Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Osteoarthritis Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Osteoarthritis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Osteoarthritis Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Osteoarthritis Drugs Sales (MT) by Type (2016-2021)
Table 39. Global Osteoarthritis Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Osteoarthritis Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Osteoarthritis Drugs Revenue Share by Type (2016-2021)
Table 42. Global Osteoarthritis Drugs Price (USD/Kg) by Type (2016-2021)
Table 43. Global Osteoarthritis Drugs Sales (MT) by Application (2016-2021)
Table 44. Global Osteoarthritis Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Osteoarthritis Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Osteoarthritis Drugs Revenue Share by Application (2016-2021)
Table 47. Global Osteoarthritis Drugs Price (USD/Kg) by Application (2016-2021)
Table 48. Johnson & Johnson Corporation Information
Table 49. Johnson & Johnson Description and Business Overview
Table 50. Johnson & Johnson Osteoarthritis Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. Johnson & Johnson Osteoarthritis Drugs Product
Table 52. Johnson & Johnson Recent Developments/Updates
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Business Overview
Table 55. Pfizer Osteoarthritis Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. Pfizer Osteoarthritis Drugs Product
Table 57. Pfizer Recent Developments/Updates
Table 58. Eli Lilly Corporation Information
Table 59. Eli Lilly Description and Business Overview
Table 60. Eli Lilly Osteoarthritis Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Eli Lilly Osteoarthritis Drugs Product
Table 62. Eli Lilly Recent Developments/Updates
Table 63. Abbott Corporation Information
Table 64. Abbott Description and Business Overview
Table 65. Abbott Osteoarthritis Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Abbott Osteoarthritis Drugs Product
Table 67. Abbott Recent Developments/Updates
Table 68. GlaxoSmithKline Corporation Information
Table 69. GlaxoSmithKline Description and Business Overview
Table 70. GlaxoSmithKline Osteoarthritis Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. GlaxoSmithKline Osteoarthritis Drugs Product
Table 72. GlaxoSmithKline Recent Developments/Updates
Table 73. Sanofi Corporation Information
Table 74. Sanofi Description and Business Overview
Table 75. Sanofi Osteoarthritis Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. Sanofi Osteoarthritis Drugs Product
Table 77. Sanofi Recent Developments/Updates
Table 78. Flexion Therapeutics Corporation Information
Table 79. Flexion Therapeutics Description and Business Overview
Table 80. Flexion Therapeutics Osteoarthritis Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. Flexion Therapeutics Osteoarthritis Drugs Product
Table 82. Flexion Therapeutics Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Osteoarthritis Drugs Distributors List
Table 86. Osteoarthritis Drugs Customers List
Table 87. Osteoarthritis Drugs Market Trends
Table 88. Osteoarthritis Drugs Growth Drivers
Table 89. Osteoarthritis Drugs Market Challenges
Table 90. Osteoarthritis Drugs Market Restraints
Table 91. Global Osteoarthritis Drugs Sales Forecast by Type (2022-2027) & (MT)
Table 92. Global Osteoarthritis Drugs Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Osteoarthritis Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Osteoarthritis Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Osteoarthritis Drugs Sales Forecast by Application (2022-2027) & (MT)
Table 96. Global Osteoarthritis Drugs Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Osteoarthritis Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Osteoarthritis Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Osteoarthritis Drugs Sales Forecast by Region (2022-2027) & (MT)
Table 100. Global Osteoarthritis Drugs Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Osteoarthritis Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Osteoarthritis Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Osteoarthritis Drugs
Figure 2. Global Osteoarthritis Drugs Market Share by Type in 2020 & 2027
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. External Product Picture
Figure 6. Global Osteoarthritis Drugs Market Share by Application in 2020 & 2027
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Global Osteoarthritis Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Osteoarthritis Drugs Market Size 2016-2027 (US$ Million)
Figure 12. Global Osteoarthritis Drugs Sales 2016-2027 (MT)
Figure 13. Global Osteoarthritis Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Osteoarthritis Drugs Sales Share by Manufacturers in 2020
Figure 15. Global Osteoarthritis Drugs Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Osteoarthritis Drugs Players: Market Share by Revenue in 2020
Figure 17. Osteoarthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Osteoarthritis Drugs Sales Market Share by Region (2016-2021)
Figure 19. Global Osteoarthritis Drugs Sales Market Share by Region in 2020
Figure 20. Global Osteoarthritis Drugs Revenue Market Share by Region (2016-2021)
Figure 21. Global Osteoarthritis Drugs Revenue Market Share by Region in 2020
Figure 22. U.S. Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Osteoarthritis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Osteoarthritis Drugs by Type (2016-2021)
Figure 47. Sales Market Share of Osteoarthritis Drugs by Application (2016-2021)
Figure 48. Sales Market Share of Osteoarthritis Drugs by Application in 2020
Figure 49. Revenue Share of Osteoarthritis Drugs by Application (2016-2021)
Figure 50. Revenue Share of Osteoarthritis Drugs by Application in 2020
Figure 51. Manufacturing Cost Structure of Osteoarthritis Drugs
Figure 52. Manufacturing Process Analysis of Osteoarthritis Drugs
Figure 53. Osteoarthritis Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed